VeriMomtripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
Related ingredients
Frequently asked questions
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 est-il sûr pendant l'allaitement ?
- No data indicating reproductive or lactation hazards, no regulatory classifications for breastfeeding risk. Topical cosmetic peptides are large molecules with low dermal penetration in available literature and no evidence of transfer into breast milk or lactation-specific adverse effects in human studies or regulatory assessments (sources: CosIng, PubChem, absence of SCCS/CIR concerns).
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 est-il sûr pour la peau de bébé ?
- No evidence of developmental or infant‑specific reproductive toxicity. Peptides used in cosmetics are high molecular weight and generally show negligible dermal absorption; therefore exposure to infants (0–3 yr) from typical topical cosmetic use is expected to be minimal and no infant‑specific hazard is documented. No harmonised CLP flags or published infant toxicity data were found (sources: CosIng, PubChem, PubMed literature absence).
- Comment VeriMom évalue-t-il tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 ?
- VeriMom évalue tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.